Schedule 13G ownership disclosure

KAZIA THERAPEUTICS LTD

American Depository Shares · CUSIP: 48669G105

Event date: 2025-12-31

Filing-level shares
1.00
Percent of class
0.0%
  • Dauntless Investment Group, LLC

    Shares: 1.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002044285-26-000003
Form type
SCHEDULE 13G/A
Filer
Dauntless Investment Group, LLC
CIK
CIK 2044285
Filed
Feb 12, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub